Search
Patexia Research
Case number 2:18-cv-09880

ADAPT PHARMA OPERATIONS LIMITED et al v. TEVA PHARMACEUTICALS USA, INC. et al > Documents

Date Field Doc. No.Description (Pages)
May 22, 2019 21 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by CHARLES H. CHEVALIER on behalf of ADAPT PHARMA INC., ADAPT PHARMA LIMITED, ADAPT PHARMA OPERATIONS LIMITED, OPIANT PHARMACEUTICALS, INC. (CHEVALIER, CHARLES)
Apr 24, 2019 19 Opinion (14)
Docket Text: OPINION. Signed by Chief Judge Jose L. Linares on 4/22/2019. (sms)
Apr 24, 2019 20 Order (2)
Docket Text: ORDER; that a ruling on the indefiniteness of the term "delivery time" would not be appropriate at the claims construction stage, and therefore, the Court reserves its decision on the indefiniteness of said term until the trial of this matter; the term a single reservoir comprising a pharmaceutical composition which is an aqueous solution of about 100 ul" as used in United States Patent Numbers 9,211,253 and 9,468,747 requires no further construction; etc. Signed by Chief Judge Jose L. Linares on 4/24/2019. (sms)
Oct 11, 2018 N/A Terminated Case (0)
Docket Text: ***Civil Case Terminated. (gl, )
Oct 11, 2018 18 Scheduling Order (5)
Docket Text: STIPULATION AND ORDER REGARDING CASE CONSOLIDATION: The parties agree to consolidate the 18-9880 action into the 16-7721 consolidated action for all purposes, etc. Final Pretrial Conference set for 7/19/2019 10:00 AM before Magistrate Judge Joseph A. Dickson. Expert Discovery shall close on 6/14/2019. Final Pretrial Order due by 7/16/2019. Signed by Magistrate Judge Joseph A. Dickson on 10/11/2018. (gl, )
Oct 1, 2018 17 Redacted Document (2)
Docket Text: REDACTION to [16] Letter,, by TEVA PHARMACEUTICALS INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC.. (WALSH, LIZA)
Sep 12, 2018 15 Letter (6)
Docket Text: Letter from Liza M. Walsh to Judge Joseph A. Dickson, U.S.M.J., Enclosing Stipulation and Proposed Order on Consolidation and Proposed Schedule. (WALSH, LIZA)
Sep 11, 2018 12 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by LIZA M. WALSH on behalf of TEVA PHARMACEUTICALS INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC. (WALSH, LIZA)
Sep 11, 2018 13 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by ELEONORE OFOSU-ANTWI on behalf of TEVA PHARMACEUTICALS INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC. (OFOSU-ANTWI, ELEONORE)
Sep 11, 2018 14 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by WILLIAM T. WALSH, JR on behalf of TEVA PHARMACEUTICALS INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC. (WALSH, WILLIAM)
Jul 27, 2018 11 Answer to Counterclaim (7)
Jul 27, 2018 11 Certificate of Service (2)
Jul 27, 2018 11 Main Document (7)
Docket Text: ANSWER to Counterclaim by ADAPT PHARMA INC., ADAPT PHARMA LIMITED, ADAPT PHARMA OPERATIONS LIMITED, OPIANT PHARMACEUTICALS, INC.. (Attachments: # (1) Certificate of Service)(LIZZA, CHARLES)
Jul 19, 2018 10 Letter (6)
Docket Text: Letter from Plaintiffs to the Hon. Joseph A. Dickson, U.S.M.J.. (LIZZA, CHARLES)
Jul 17, 2018 N/A Update Answer Due Deadline (0)
Docket Text: Clerk`s Text Order - The document [9] Application for Clerk's Order to Ext Answer/Proposed Order, submitted by ADAPT PHARMA LIMITED, ADAPT PHARMA INC., ADAPT PHARMA OPERATIONS LIMITED, OPIANT PHARMACEUTICALS, INC. has been GRANTED. The answer due date has been set for 07/30/2018. (ek)
Jul 16, 2018 9 Application for Clerk's Order to Ext Answer/Proposed Order (2)
Docket Text: Application and Proposed Order for Clerk's Order to extend time to answer as to Plaintiffs' time to answer, move, or otherwise reply to Defendants Teva Pharmaceuticals USA, Inc.'s and Teva Pharmaceuticals Industries Ltd.'s Answer to Complaint and Counterclaim.. (LIZZA, CHARLES)
Jun 25, 2018 7 Answer to Complaint (14)
Docket Text: ANSWER to Complaint , COUNTERCLAIM against All Plaintiffs by All Defendants.(PATUNAS, MICHAEL)
Jun 25, 2018 8 Corporate Disclosure Statement (aty) (3)
Docket Text: Corporate Disclosure Statement by TEVA PHARMACEUTICALS INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC. identifying TEVA PHARMACEUTICAL INDUSTRIES LTD. as Corporate Parent.. (PATUNAS, MICHAEL)
Jun 4, 2018 6 AO120 Patent/Trademark Form (1)
Jun 4, 2018 6 Complaint and Exhibits (59)
Jun 4, 2018 6 Main Document (1)
Docket Text: AO120 Patent/Trademark Form filed. (Attachments: # (1) Complaint and Exhibits) (ek)
May 31, 2018 N/A Add and Terminate Judges (0)
Docket Text: Chief Judge Jose L. Linares and Magistrate Judge Joseph A. Dickson added. (eu, )
May 31, 2018 3 Summons Issued (2)
Docket Text: SUMMONS ISSUED as to TEVA PHARMACEUTICALS INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. Issued By *ELISAVETA KALLUCI* (ek)
May 31, 2018 4 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by WILLIAM C. BATON on behalf of ADAPT PHARMA INC., ADAPT PHARMA LIMITED, ADAPT PHARMA OPERATIONS LIMITED, OPIANT PHARMACEUTICALS, INC. (BATON, WILLIAM)
May 31, 2018 5 Notice of Appearance (2)
Docket Text: NOTICE of Appearance by SARAH ANN SULLIVAN on behalf of ADAPT PHARMA INC., ADAPT PHARMA LIMITED, ADAPT PHARMA OPERATIONS LIMITED, OPIANT PHARMACEUTICALS, INC. (SULLIVAN, SARAH)
May 30, 2018 1 Complaint (58)
May 30, 2018 1 Civil Cover Sheet (1)
May 30, 2018 2 Corporate Disclosure Statement (aty) (3)
Docket Text: Corporate Disclosure Statement by ADAPT PHARMA INC., ADAPT PHARMA LIMITED, ADAPT PHARMA OPERATIONS LIMITED, OPIANT PHARMACEUTICALS, INC.. (LIZZA, CHARLES)
May 30, 2018 1 Main Document (58)
Docket Text: COMPLAINT against TEVA PHARMACEUTICALS INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC. ( Filing and Admin fee $ 400 receipt number 0312-8775197), filed by OPIANT PHARMACEUTICALS, INC., ADAPT PHARMA OPERATIONS LIMITED, ADAPT PHARMA LIMITED, ADAPT PHARMA INC.. (Attachments: # (1) Civil Cover Sheet)(LIZZA, CHARLES)
May 30, 2018 1 Complaint* (1)
Menu